Ocular Therapeutix (OCUL) Debt Ratio (2013 - 2026)

Ocular Therapeutix (OCUL) posted quarterly Debt Ratio of 0.11 for Q2 2026, down 29.99% year-over-year from 0.15 in Q2 2025, and up 10.23% on a QoQ basis from 0.1 in Q1 2026.

Ocular Therapeutix (OCUL) Debt Ratio (2013 - 2026) Analysis & Trends

Ocular Therapeutix has reported Debt Ratio for 14 years, with the latest figure at 0.11 in Q2 2026.

  • Debt Ratio for Q2 2026 came in at 0.11, down 29.99% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.11 (down 29.99% YoY), and the FY2025 annual result was 0.09, down 40.99% from the prior year.
  • Debt Ratio improved to 0.11 in Q2 2026, from 0.1 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.4 in Q3 2023 and troughed at 0.09 in Q4 2025.
  • A 5-year average of 0.17 and a median of 0.15 in 2025 frame the typical range for Debt Ratio.
  • The widest annual swing landed in 2023, when Debt Ratio jumped 152.45%; it then tumbled 65.52% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.17 in 2022, then soared by 54.27% to 0.26 in 2023, then plunged by 42.68% to 0.15 in 2024, then tumbled by 40.99% to 0.09 in 2025, then advanced by 22.83% to 0.11 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.11 in Q2 2026, 0.1 in Q1 2026, and 0.09 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Ocular Therapeutix 2.20 Bn 2.20 Bn 11.46 Mn 0.11

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11
Mar 31, 2026 0.10
Dec 31, 2025 0.09
Sep 30, 2025 0.17
Jun 30, 2025 0.15
Mar 31, 2025 0.17
Dec 31, 2024 0.15
Sep 30, 2024 0.14
Jun 30, 2024 0.13
Mar 31, 2024 0.12
Dec 31, 2023 0.26
Sep 30, 2023 0.40
Jun 30, 2023 0.19
Mar 31, 2023 0.20
Dec 31, 2022 0.17
Sep 30, 2022 0.16
Jun 30, 2022 0.15
Mar 31, 2022 0.13
Dec 31, 2021 0.12
Sep 30, 2021 0.11